Table 1 Comparison of baseline recipient data between patients undergoing liver transplantation assigned to 28% and 80% postoperative FiO₂

Patient age (years)

48.6 (39.0–58.9)

50.7 (40.3–58.6)

.673

Male sex

55 (55.6%)

59 (62.8%)

.380

Body mass index (kg/m²)

25.0 (22.9–27.7)

25.9 (23.2–28.3)

.360

MELD

14 (11–18)

14 (10–20)

.739

Child-Turcotte-Pugh class:

.962

 A

37 (37.4%)

34 (36.2%)

 B

46 (46.5%)

43 (45.7%)

 C

16 (16.2%)

17 (18.1%)

 Alcoholic liver disease

27 (27.3%)

29 (30.9%)

.636

 HCV

14 (14.1%)

14 (14.9%)

> .999

 HBV

6 (6.1%)

13 (13.8%)

.091

 Primary sclerosing cholangitis

15 (15.2%)

13 (13.8%)

.840

 Primary biliary cirrhosis

12 (12.1%)

14 (14.9%)

.675

 Autoimmune hepatitis

16 (16.2%)

13 (13.8%)

.691

 Non-alcoholic steatohepatitis

1 (1.0%)

1 (1.1%)

> .999

 Wilson’s disease

3 (3.0%)

2 (2.1%)

> .999

 Secondary biliary cirrhosis

0 (0.0%)

1 (1.1%)

.487

 Unknown

4 (4.0%)

5 (5.3%)

.743

Smoking

7 (7.1%)

3 (3.2%)

.332

ASA classification ≥ 3

91 (91.9%)

89 (94.7%)

.569

 Diabetes

9 (9.1%)

15 (16.0%)

.191

 Coronary artery disease

3 (3.0%)

3 (3.2%)

> .999

 Hypertension

18 (18.2%)

17 (18.1%)

> .999

 Ulcerative colitis

7 (7.1%)

4 (4.3%)

.538

Colonization with multidrug-resistant pathogens

9 (9.1%)

11 (11.7%)

.640

SENIC:

.615

 2

74 (74.7%)

72 (76.6%)

 3

25 (25.3%)

21 (22.3%)

 4

0 (0.0%)

1 (1.1%)

NNISS:

.435

 0

6 (6.1%)

3 (3.2%)

 1

69 (69.7%)

62 (66.0%)

 2

24 (24.2%)

29 (30.8%)

 Hemoglobin (g/dL)

11.6 (10–13.1)

11.4 (9.7–13.1)

.509

 White blood cell count (10³/mm³)

5.3 (3.6–7.1)

5.6 (3.8–7.8)

.552

 Platelets (10³/mm³)

100 (63–168)

114 (60–173)

.856

 Albumins (g/dL)

3.5 (3.0–4.0)

3.6 (3.1–4.0)

.784

 Bilirubin (mg/dL)

2.5 (1.2–5.3)

2.0 (1.1–4.2)

.645

 Creatinine (mg/dL)

0.9 (0.7–1.2)

0.9 (0.7–1.1)

.836

 International normalized ratio

1.3 (1.1–1.5)

1.3 (1.2–1.6)

.550

 C-reactive protein (mg/L)

7.8 (2.3–19.5)

8.5 (3.5–17.3)

.769